Evaluation of the relationship between [18F]FDG and P-glycoprotein expression: an experimental study
详细信息查看全文 | 推荐本文 |
摘要

Introduction

P-glycoprotein (P-gp) is a cell-membrane-associated protein that transports a variety of drug substrates. We sought to evaluate the relationship between 2-[18F]fluoro-2-deoxy-d-glucose ([18F]FDG) and P-gp expression using breast carcinoma Bcap37/multidrug resistant (MDR1) and Bcap37 in vitro and in vivo.

Methods

The function of P-gp expressed in Bcap37/MDR1 cells was evaluated using verapamil (VER), a classical inhibitor of P-gp. The accumulation of 99mTc-methoxyisobutylisonitrile ([99mTc]MIBI) in vitro was measured. In vivo imaging of severe combined immune deficiency (SCID) mice implanted with Bcap37 and Bcap37/MDR1 cells was performed by scintigraphy and micro-positron emission tomography (PET).

Results

The uptake of [99mTc]MIBI was 0.62%卤0.05%in the Bcap37/MDR1 cells and 2.02%卤0.28%in the Bcap37 cells. VER significantly increased the uptake of [99mTc]MIBI in the Bcap37/MDR1 cells (1.90%卤0.09%) but not in the Bcap37 cells (2.15%卤0.27%). In vivo, neither the Bcap37 nor Bcap37/MDR1 tumors grown in the SCID mice could be detected by [99mTc]MIBI scintigraphy. Both the Bcap37 and Bcap37/MDR1 tumors were visible by micro-PET. The mean standardized uptake value (SUV) was significantly higher in the Bcap37 tumors (1.00卤0.06) than in the Bcap37/MDR1 (0.67卤0.11) tumors. VER significantly increased the mean SUV in the Bcap37/MDR1 tumors (1.02卤0.16) but not in the Bcap37 tumors (1.09卤0.22).

Conclusions

[18F]FDG combined with VER may be an effective noninvasive method of determining P-gp expression in tumors.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700